Where every study is worthy of tailored protocols
At IPST we rise to the challenge of designing out-of-the-box inventive studies with new endpoints, novel routes of administration and pioneering models.
We have conducted more than 3,000 preclinical safety and efficacy studies and over 120 GLP-compliant studies in support of FDA, EMEA, Health Canada and MoHW.
Strengthen your team with IPST
At IPST we solve problems in collaboration with our clients. We believe in delivering spectacular results – together.
-
Know-how propels projects past hurdles. In drug discovery, it means experienced staff constantly refining the best models – in collaboration with our clients.
-
Leverage IPST’s unique combination of wisdom, skills and experience to maximize the scientific and strategic value of your data.
-
With 36 000 square feet of purpose-designed state-of-the-art labs serving four fields of research, IPST is your reliable and cost-effective de-risking drug discovery partner.
Why IPST?
Outsourcing pivotal work can be daunting.
It requires trust achieved over years of successful teamwork. IPST fills in gaps in your processes to accelerate development.
Meet your team
Our senior management team is fully engaged in every project. Every doubt, every triumph, you know who to call.
Our expertise
Established in 1999, we have conducted thousands of preclinical cardiac safety and efficacy studies and GLP-compliant studies in support of FDA, EMEA, Health Canada and MoHW requirements.
Learn more
Let’s talk
At IPST we believe each study is worthy of tailored protocols designed to maximize the scientific and strategic value of the data generated. We believe in taking ownership of the studies entrusted to IPST while ensuring mutual collaboration for developing and agreeing to overall project plans.
Contact us